• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要英国卫生研究资助机构资助研究的发表率:一项队列研究。

Publication rate for funded studies from a major UK health research funder: a cohort study.

机构信息

National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre (NETSCC), University of Southampton, Southampton, Hampshire, UK.

出版信息

BMJ Open. 2013 May 2;3(5):e002521. doi: 10.1136/bmjopen-2012-002521.

DOI:10.1136/bmjopen-2012-002521
PMID:23645914
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3646183/
Abstract

OBJECTIVES

This study aimed to investigate what percentage of National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme-funded projects have published their final reports in the programme's journal HTA and to explore reasons for non-publication.

DESIGN

Retrospective cohort study.

SETTING

Failure to publish findings from research is a significant area of research waste. It has previously been suggested that potentially over 50% of studies funded are never published.

PARTICIPANTS

All NIHR HTA projects with a planned submission date for their final report for publication in the journal series on or before 9 December 2011 were included.

PRIMARY AND SECONDARY OUTCOME MEASURES

The projects were classified according to the type of research, whether they had been published or not; if not yet published, whether they would be published in the future or not. The reasons for non-publication were investigated.

RESULTS

628 projects were included: 582 (92.7%) had published a monograph; 19 (3%) were expected to publish a monograph; 13 (2.1%) were discontinued studies and would not publish; 12 (1.9%) submitted a report which did not lead to a publication as a monograph; and two (0.3%) did not submit a report. Overall, 95.7% of HTA studies either have published or will publish a monograph: 94% for those commissioned in 2002 or before and 98% for those commissioned after 2002. Of the 27 projects for which there will be no report, the majority (21) were commissioned in 2002 or before. Reasons why projects failed to complete included failure to recruit; issues concerning the organisation where the research was taking place; drug licensing issues; staffing issues; and access to data.

CONCLUSIONS

The percentage of HTA projects for which a monograph is published is high. The advantages of funding organisations requiring publication in their own journal include avoidance of publication bias and research waste.

摘要

目的

本研究旨在调查英国国家卫生与临床优化研究所(NIHR)卫生技术评估(HTA)计划资助的项目中,有多少项目在该计划的期刊 HTA 上发表了最终报告,并探讨未发表的原因。

设计

回顾性队列研究。

设置

未能发表研究结果是研究浪费的一个重要领域。此前有人提出,超过 50%的资助研究从未发表过。

参与者

所有计划于 2011 年 12 月 9 日或之前提交最终报告供期刊系列发表的 NIHR HTA 项目均被纳入研究。

主要和次要结果

根据研究类型对项目进行分类,无论是否已发表;如果尚未发表,未来是否会发表。调查了未发表的原因。

结果

共纳入 628 个项目:582 个(92.7%)已发表专着;19 个(3%)预计将发表专着;13 个(2.1%)为已终止的研究,不会发表;12 个(1.9%)提交的报告未作为专着发表;2 个(0.3%)未提交报告。总体而言,95.7%的 HTA 研究已经或将要发表专着:2002 年或之前委托的研究占 94%,2002 年之后委托的研究占 98%。在 27 个不会有报告的项目中,大多数(21 个)是在 2002 年或之前委托的。项目未能完成的原因包括招募失败;研究进行地组织的问题;药物许可问题;人员配备问题;以及数据获取问题。

结论

发表专着的 HTA 项目比例很高。资助机构要求在自己的期刊上发表的优点包括避免发表偏倚和研究浪费。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c29d/3646183/92927c012f7d/bmjopen2012002521f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c29d/3646183/dda496a040bc/bmjopen2012002521f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c29d/3646183/92927c012f7d/bmjopen2012002521f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c29d/3646183/dda496a040bc/bmjopen2012002521f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c29d/3646183/92927c012f7d/bmjopen2012002521f02.jpg

相似文献

1
Publication rate for funded studies from a major UK health research funder: a cohort study.主要英国卫生研究资助机构资助研究的发表率:一项队列研究。
BMJ Open. 2013 May 2;3(5):e002521. doi: 10.1136/bmjopen-2012-002521.
2
Time to publication for NIHR HTA programme-funded research: a cohort study.英国国家卫生与临床优化研究所(NIHR)卫生技术评估(HTA)项目资助的研究的出版时间:一项队列研究。
BMJ Open. 2013 Nov 27;3(11):e004121. doi: 10.1136/bmjopen-2013-004121.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
5
The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.2003 - 2013年英国国家卫生研究院卫生技术评估项目的影响:多方法评估
Health Technol Assess. 2015 Aug;19(67):1-291. doi: 10.3310/hta19670.
6
The clinical relevance and newsworthiness of NIHR HTA-funded research: a cohort study.英国国家卫生研究院卫生技术评估(NIHR HTA)资助研究的临床相关性和新闻价值:一项队列研究。
BMJ Open. 2014 May 7;4(5):e004556. doi: 10.1136/bmjopen-2013-004556.
7
Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).体外受精中胚胎的选择性冷冻与新鲜胚胎移植:英国的一项多中心随机对照试验(E-Freeze)。
Hum Reprod. 2022 Mar 1;37(3):476-487. doi: 10.1093/humrep/deab279.
8
Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study.可行性研究和预试验在随机对照试验中的作用:一项横断面研究。
BMJ Open. 2018 Sep 25;8(9):e022233. doi: 10.1136/bmjopen-2018-022233.
9
Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.研究结果对同行评审医学期刊投稿与录用指标的影响:葛兰素史克所有已完成的人体药物研究的六年回顾性分析
BMJ. 2017 Apr 21;357:j1726. doi: 10.1136/bmj.j1726.
10
Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme.临床试验元数据:定义并提取由英国国家卫生研究院卫生技术评估项目资助的125项随机临床试验在设计、实施、结果和成本方面的元数据。
Health Technol Assess. 2015 Feb;19(11):1-138. doi: 10.3310/hta19110.

引用本文的文献

1
Digital Tools to Support the Systematic Review Process: An Introduction.支持系统评价过程的数字工具:简介
J Eval Clin Pract. 2025 Apr;31(3):e70100. doi: 10.1111/jep.70100.
2
Is our public research money well spent? Publication of research outputs from Health Research Council of New Zealand-funded studies: a cross-sectional study.我们的公共研究资金是否得到了有效利用?对新西兰健康研究理事会资助研究的产出成果的发表情况进行调查:一项横断面研究。
BMJ Open. 2023 May 31;13(5):e072446. doi: 10.1136/bmjopen-2023-072446.
3
Publication and non-publication of clinical trials in PTSD: an overview.

本文引用的文献

1
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.美国国立卫生研究院资助的临床试验在 ClinicalTrials.gov 上的发表情况:横断面分析。
BMJ. 2012 Jan 3;344:d7292. doi: 10.1136/bmj.d7292.
2
Dissemination and publication of research findings: an updated review of related biases.研究结果的传播和发表:相关偏倚的更新综述。
Health Technol Assess. 2010 Feb;14(8):iii, ix-xi, 1-193. doi: 10.3310/hta14080.
3
Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias.
创伤后应激障碍临床试验的发表与未发表情况概述。
Res Integr Peer Rev. 2019 Jul 25;4:15. doi: 10.1186/s41073-019-0074-6. eCollection 2019.
4
A novel approach to sharing all available information from funded health research: the NIHR Journals Library.一种分享所有已资助健康研究信息的新方法:NIHR 期刊库。
Health Res Policy Syst. 2018 Jul 31;16(1):70. doi: 10.1186/s12961-018-0339-4.
5
Involving clinical experts in prioritising topics for health technology assessment: a randomised controlled trial.让临床专家参与卫生技术评估议题的优先级排序:一项随机对照试验。
BMJ Open. 2017 Aug 21;7(8):e016104. doi: 10.1136/bmjopen-2017-016104.
6
Time to publication for publicly funded clinical trials in Australia: an observational study.澳大利亚公共资助临床试验的发表时间:一项观察性研究。
BMJ Open. 2017 Mar 22;7(3):e012212. doi: 10.1136/bmjopen-2016-012212.
7
Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme.随机对照试验中参与者的招募与保留:对由英国卫生技术评估计划资助并发表的试验的综述
BMJ Open. 2017 Mar 20;7(3):e015276. doi: 10.1136/bmjopen-2016-015276.
8
Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example.评估预后因素研究中未发表研究的范围:以膀胱癌中p53免疫组化的系统评价为例
BMJ Open. 2016 Aug 16;6(8):e009972. doi: 10.1136/bmjopen-2015-009972.
9
Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort.英国国家卫生研究院卫生技术评估项目资助的研究对英国国家卫生与临床优化研究所临床指南的影响:一项回顾性队列研究。
Health Res Policy Syst. 2015 Aug 22;13:37. doi: 10.1186/s12961-015-0025-8.
10
Using ClinicalTrials.gov to supplement information in ophthalmology conference abstracts about trial outcomes: a comparison study.利用ClinicalTrials.gov补充眼科会议摘要中关于试验结果的信息:一项比较研究。
PLoS One. 2015 Jun 24;10(6):e0130619. doi: 10.1371/journal.pone.0130619. eCollection 2015.
抗癌药物治疗乳腺癌的研究发表时间,以及潜在的发表偏倚。
Int J Technol Assess Health Care. 2010 Jan;26(1):110-6. doi: 10.1017/S0266462309990778.
4
Avoidable waste in the production and reporting of research evidence.研究证据生产与报告中的可避免浪费。
Lancet. 2009 Jul 4;374(9683):86-9. doi: 10.1016/S0140-6736(09)60329-9. Epub 2009 Jun 12.
5
Publication bias in clinical trials due to statistical significance or direction of trial results.由于试验结果的统计学显著性或方向导致的临床试验中的发表偏倚。
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):MR000006. doi: 10.1002/14651858.MR000006.pub3.
6
Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review.乳腺癌抗癌药物研究的完全发表时间及发表偏倚的可能性:一项简短的系统评价
Health Technol Assess. 2008 Oct;12(32):iii, ix-x, 1-46. doi: 10.3310/hta12320.
7
An assessment of the impact of the NHS Health Technology Assessment Programme.英国国家医疗服务体系(NHS)卫生技术评估项目的影响评估
Health Technol Assess. 2007 Dec;11(53):iii-iv, ix-xi, 1-180. doi: 10.3310/hta11530.
8
Full publication of results initially presented in abstracts.最初以摘要形式呈现的研究结果的完整发表。
Cochrane Database Syst Rev. 2007 Apr 18(2):MR000005. doi: 10.1002/14651858.MR000005.pub3.
9
Factors associated with failure to publish large randomized trials presented at an oncology meeting.与在肿瘤学会议上公布的大型随机试验未发表相关的因素。
JAMA. 2003 Jul 23;290(4):495-501. doi: 10.1001/jama.290.4.495.
10
Publication bias: evidence of delayed publication in a cohort study of clinical research projects.发表偏倚:临床研究项目队列研究中延迟发表的证据。
BMJ. 1997 Sep 13;315(7109):640-5. doi: 10.1136/bmj.315.7109.640.